Surviving 2008: Lay-Offs, Scale-Backs, Creative Financings
By Karen Pihl-Carey
Monday, December 29, 2008
Amid the economic carnage of 2008, the biotech industry stands as a survivor, although with roughly 5,000 jobs lost, a number of shelved programs and no promises of an easier time for financings in the new year, the victory is melancholy at best.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.